The systemic inflammatory response syndrome following cardiac surgery: different expression of proinflammatory cytokines and procalcitonin in patients with and without multiorgan dysfunctions

Cardiopulmonary bypass is associated with an injury that may cause pathophysiological changes in the form of systemic inflammatory response syndrome (SIRS) or multiple organ dysfunction syndrome (MODS). In the present study, we investigated the inflammatory response of patients with multiple organ dysfunctions following open-heart surgery. Plasma levels of cytokines (IL-1β, IL-6, IL-8, IL-18) and procalcitonin (PCT) were measured on the first four postoperative days in 12 adult male patients with SIRS and two or more organ dysfunctions after myocar-dial revascularization (MODS group), and 15 patients without organ dysfunctions (SIRS group). All cytokines (except IL-1β) and PCT were significantly elevated in MODS patients, with peak values at the first two postoperative days. The results of our study show a different expression of members of the IL-1 family following extracorporeal circulation. For the first time, we can document that IL-18 is involved in the inflammatory response and the initiation of the MODS following cardiopulmonary bypass. In addition to APACHE-II score, PCT, IL-8, and IL-18 may be used as parameters for the prognosis of patients with organ dysfunctions after cardiac surgery. Furthermore, it must be noted that the duration of the surgical procedure is one of the most important factors for the initiation of the inflammatory response.

[1]  D. Das,et al.  Induction of Interleukin‐ 8 Expression During Cardiopulmonary Bypass , 1993, Circulation.

[2]  T. Menges,et al.  Plasma levels of immunoinhibitory cytokines interleukin-10 and transforming growth factor-beta in patients undergoing coronary artery bypass grafting. , 1997, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[3]  M. Assicot,et al.  High serum procalcitonin concentrations in patients with sepsis and infection , 1993, The Lancet.

[4]  A Haverich,et al.  Systemic inflammatory response syndrome after cardiac operations. , 1996, The Annals of thoracic surgery.

[5]  W. Konertz,et al.  Hyperprocalcitonemia in Patients with Noninfectious SIRS and Pulmonary Dysfunction Associated with Cardiopulmonary Bypass , 1998, Anesthesiology.

[6]  H. Scheld,et al.  Arterial and venous cytokine response to cardiopulmonary bypass for low risk CABG and relation to hemodynamics. , 1995, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[7]  C. Dinarello.  IL-18: A TH1-inducing, proinflammatory cytokine and new member of the IL-1 family. , 1999, The Journal of allergy and clinical immunology.

[8]  N. Nathan,et al.  Cytokine and Lipid Mediator Blood Concentrations After Coronary Artery Surgery , 1997, Anesthesia and analgesia.

[9]  R. Bone,et al.  Plasma Cytokine and Endotoxin Levels Correlate with Survival in Patients with the Sepsis Syndrome , 1993, Annals of Internal Medicine.

[10]  C. Dinarello,et al.  Biologic basis for interleukin-1 in disease. , 1996, Blood.

[11]  J. M. Lipton,et al.  Does the Duration of Cardiopulmonary Bypass or Aortic Cross-Clamp, in the Absence of Blood and/or Blood Product Administration, Influence the IL-6 Response to Cardiac Surgery? , 1998, Anesthesia and analgesia.

[12]  L. Casey.  Role of cytokines in the pathogenesis of cardiopulmonary-induced multisystem organ failure. , 1993, The Annals of thoracic surgery.

[13]  J. Vincent,et al.  Human cytokine responses to cardiac transplantation and coronary artery bypass grafting. , 1996, The Journal of thoracic and cardiovascular surgery.

[14]  K. Taylor,et al.  SIRS--the systemic inflammatory response syndrome after cardiac operations. , 1996, The Annals of thoracic surgery.

[15]  J. Snick,et al.  Interleukin-6: an overview. , 1990, Annual review of immunology.

[16]  W. Knaus,et al.  Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. , 1992, Chest.

[17]  D. E. Lawrence,et al.  APACHE—acute physiology and chronic health evaluation: a physiologically based classification system , 1981, Critical care medicine.

[18]  T. Menges,et al.  Acute phase and opsonin response in cardiac surgery patients: influence of underlying cardiac disease , 1998, Perfusion.

[19]  F. Mohr,et al.  Improved outcome of APACHE II score-defined escalating systemic inflammatory response syndrome in patients post cardiac surgery in 1996 compared to 1988-1990: the ESSICS-study pilot project. , 2000, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[20]  R. Chioléro,et al.  Cytokines, nitrite/nitrate, soluble tumor necrosis factor receptors, and procalcitonin concentrations: comparisons in patients with septic shock, cardiogenic shock, and bacterial pneumonia. , 1997, Critical care medicine.

[21]  S. Dower,et al.  Binding of IL-1 alpha, IL-1 beta, and IL-1 receptor antagonist by soluble IL-1 receptors and levels of soluble IL-1 receptors in synovial fluids. , 1994, Journal of immunology.

[22]  C. Osmer,et al.  Alterations of the cytokine network in patients undergoing cardiopulmonary bypass , 1997, Perfusion.

[23]  M. Su,et al.  Interleukin-18 (IFNgamma-inducing factor) induces IL-8 and IL-1beta via TNFalpha production from non-CD14+ human blood mononuclear cells. , 1998, The Journal of clinical investigation.

[24]  R. Holzheimer,et al.  IL-6 and TNF alpha release in association with neutrophil activation after cardiopulmonary bypass surgery. , 1994, Infection.

[25]  R. Sauerwein,et al.  Cytokine Patterns in Patients After Major Vascular Surgery, Hemorrhagic Shock, and Severe Blunt Trauma Relation with Subsequent Adult Respiratory Distress Syndrome and Multiple Organ Failure , 1993, Annals of surgery.

[26]  G. Rocker,et al.  The Systemic Inflammatory Response to Cardiopulmonary Bypass: Pathophysiological, Therapeutic, and Pharmacological Considerations , 1997, Anesthesia and analgesia.

[27]  S Westaby,et al.  Complement and the damaging effects of cardiopulmonary bypass. , 1983, The Journal of thoracic and cardiovascular surgery.